Genetically modified cells could eliminate the need for daily injections to treat type 1 diabetes, experts have revealed.
专家透露,有了基因改良细胞,1型糖尿病患者就可不必天天注射胰岛素了。
The human cell line is genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body.
人类细胞系经基因改造后,可随着人体内血糖水平的变化产生、储存并释放胰岛素。
Scientists said the insulin-producing 'Melligen' cells show promise as a possible cure for type 1 diabetes.
科研人员表示,产生胰岛素的“Melligen”细胞有望成为1型糖尿病的新疗法。
In type 1 diabetes, the immune system destroys the pancreatic cells responsible for making insulin, a hormone crucial to converting blood sugar into energy.
1型糖尿病患者的免疫系统破坏了负责分泌胰岛素的胰腺细胞,而胰岛素是将血糖转化成能量的关键激素。
This month, they secured US patent protection for the cell line from the US Patent and Trademark Office.
这项细胞系技术本月获得美国专利商标局的专利保护.
Professor Ann Simpson, who led the team at the University of Technology, Sydney, said: 'My team and I are extremely pleased that the US patent for the Melligen cells has been granted.
【澳洲新基因改良技术:不打胰岛素也能治糖尿病】相关文章:
★ “大白兔冰淇淋”在美火爆,奶糖原料被抢光,冠生园:没授权啊
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15